“…In the past 15 years, several BNCT (Boron Neutron Capture Therapy) agents [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] have been proposed, including boronated nucleosides [5][6][7][8][9], amino acids and peptides [10,11], phospholipids [12], monoclonal antibodies, liposomes [13][14][15], closomers [16,17], and dendrimers [18,19]. Tetrapyrrolic macrocycles, a vast class of biologically relevant compounds often employed as sensitizers in anti-cancer photomedical treatments (including photodynamic therapy (PDT) [20][21][22][23][24] and photothermal therapy (PTT) [25][26][27][28]), have also been derivatized with boron-containing functions for possible use in BNCT [20,[29][30][31]…”